Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...

Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward ...

Guardant Health (GH) announced a collaboration with Boehringer Ingelheim to pursue the regulatory approval and commercialization of the ...

The prevalence of cancer is escalating at an alarming rate globally, underscoring the need for robust diagnostic solutions. Factors such as growing awareness, supportive government initiatives, and ...

Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster with Nebul's certified AI Healthcare Cloud solutionsLOS ANGELES, ...

This article examines some of the latest advances in biomarker discovery in the fields of cancer and neurodegenerative and ...

AI-driven tools for prescreening patients, predicting responses and outcomes, and guiding patient therapy are maturing and entering the market.

Keywords: Oral Cancer Diagnosis, Multidisciplinary Integration, Liquid Biopsy, Artificial Intelligence in Oncology, Biomarker Discovery, Machine Learning Applications. Important Note: All ...

Breast cancer continues to pose a significant global health challenge as the most commonly diagnosed cancer in women ...

In a study involving 43 MBC patients, the liquid biopsy test reclassified three out of five patients who were initially deemed HER2-negative by tissue biopsy as HER2-positive. This discovery ...